PHG Stock Recent News

July 17, 2025 Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution available through Philips' ECG ecosystem CAMBRIDGE, Mass. — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the Philips ECG AI Marketplace, a platform that gives cardiac care teams access to multiple vendor offerings all in one central location to help clinicians manage and implement AI-powered diagnostic tools more easily.

From July 8 to 13, Amazon shoppers can score up to 50% off the brand's best-selling smart locks — including the Philips 4200 Series Built-in Wi-Fi Fingerpr

CAMBRIDGE, Mass. & GARY, Ind.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Methodist Hospitals today announced the healthcare provider's strategic investment in Philips' advanced portfolio of image-guided therapy (IGT) solutions that integrate imaging systems and software, with specialized diagnostic and therapeutic devices. The new interventional suites will support critical health needs within the community including active stroke treatment.

Amsterdam, the Netherlands – Marking its tenth anniversary, Philips Foundation today released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around the world – a significant increase from 28 million the year before. This progress was driven by 22 new initiatives and five new early-stage capital impact investments that expanded Philips Foundation's reach, channeling Philips' health technology expertise to help address the growing burden of non-communicable diseases and maternal health challenges, predominantly at the primary care level in underserved communities. “Today, half of the global population still does not have access to healthcare. Innovation and new digital technologies, combined with an ecosystem of partners, can improve health outcomes and make progress towards a future where quality healthcare is within reach for everyone,” said Marnix van Ginneken, Chair of the Board

June 5, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2024 is 1 new common share for every 23.6353 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 30, June 2, and 3, 2025, of EUR 20.0600 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85.

June 4, 2025  Amsterdam, the Netherlands  –  Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will repurchase up to 6 million shares to cover certain of its obligations arising from its long-term incentive plans. At the current share price, the shares represent an amount of up to approximately EUR 125 million.

Demonstrated at LINNC Paris 2025, the company's latest release of SmartCT delivers fast, intelligent 3D imaging in the Angio suite — helping physicians act with greater speed and confidence during a range of critical neurovascular procedures

CAMBRIDGE, Mass. & ARLINGTON, Va.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and March of Dimes, the nation's leading nonprofit fighting for the health of all moms and babies, today announced a collaboration aimed at improving maternal health education through the Philips Avent Pregnancy+ app. Philips will integrate essential March of Dimes content into the app to help improve health literacy and create awareness for topics such as preparing fo.

May 20, 2025 Prospective, randomized, unblinded, comparative, international, multi-center clinical investigation 824 patients across 6 hospitals in Spain, Czech Republic, Denmark and the US Primary objective is to demonstrate that the new technology can reduce overall patient radiation dose without affecting coronary procedure performance. Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the RADIQAL (Radiation Dose and Image Quality Trial) trial.

May 19, 2025 VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D and 3D images in real time Catheter offers enhanced procedural guidance without the need for general anesthesia, supporting more efficient and patient-friendly care for structural heart disease Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of its VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter in Europe. Building on its success in the United States, VeriSight Pro brings real-time 3D imaging directly inside the heart, helping physicians perform procedures with greater clarity — without the need for general anesthesia.